Pharmacy Support System for Asthma

(eAMS-Pharm Trial)

Enrolling by invitation at 2 trial locations

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: Unity Health Toronto

Disqualifiers: Non-asthma patients, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new electronic system in pharmacies to improve asthma management. The Pharmacy Clinical Decision Support System for Asthma Management assists pharmacists in assessing asthma control, adjusting medications, delivering action plans, and referring patients with severe asthma to specialists. The goal is to enhance patient care by using patient data to guide pharmacy staff. People with asthma who visit one of the study pharmacies can participate. As an unphased trial, this study provides a unique opportunity for patients to contribute to the development of innovative asthma management tools.

Do I need to stop my current medications for this asthma trial?

The trial information does not specify if you need to stop your current medications. It seems to focus on using your existing medication data to help manage your asthma better.

What prior data suggests that this electronic asthma management system is safe for use in pharmacies?

Research has shown that systems like the eAMS-Pharm are generally safe for healthcare use. These systems assist pharmacists in managing asthma by analyzing patient data. In previous studies, similar systems improved asthma outcomes without causing harm.

The eAMS-Pharm uses patient information, such as asthma control and risk of flare-ups, to assist pharmacists. No reports have indicated any negative effects from the system. Instead, it helps pharmacists provide better care by closely following asthma guidelines.

Evidence so far suggests that the eAMS-Pharm is safe for both pharmacists and patients. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the Pharmacy Clinical Decision Support System for Asthma Management because it introduces a tech-driven approach to asthma care. Unlike traditional treatments that rely heavily on medication and patient self-management, this system empowers pharmacists with real-time data and recommendations. This could lead to more personalized and timely intervention, potentially improving patient outcomes and adherence to asthma management plans. By integrating electronic tools into pharmacies, the system aims to enhance the coordination of care and optimize treatment strategies for individuals with asthma.

What evidence suggests that this electronic asthma management system is effective for asthma?

This trial will compare the effectiveness of the Electronic Asthma Management System (eAMS-Pharm) with standard pharmacy care. Research has shown that eAMS-Pharm effectively manages asthma by using patient information to assist pharmacists in making better decisions about asthma care. Studies indicate that computerized tools like eAMS-Pharm improve asthma treatment by ensuring patients receive guideline-based care. The system reviews symptoms and suggests management strategies, leading to better asthma control. This approach helps close the gap between recommended care and what patients actually receive, enhancing overall asthma management. ^{2 3 4 6 7}

Are You a Good Fit for This Trial?

This trial is for individuals with asthma who visit pharmacies that will implement the eAMS-Pharm system. It's designed to help pharmacists improve asthma care by assessing control, adjusting medication, providing action plans, and referring severe cases to specialists.

Inclusion Criteria

Pharmacy team members who are staff (pharmacists/RPhTs/assistants/students) at any one of the three study pharmacies

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-intervention

A retrospective, pharmacy chart review will assess pharmacy-delivered care in the six-month pre-intervention period

6 months

Intervention

The eAMS-Pharm is provided to pharmacists for use in eligible patients, assessing asthma control, medication adjustments, and action plan creation

6 months

Multiple visits (virtual and in-person)

Follow-up

Participants are monitored for safety and effectiveness after the intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Pharmacy Clinical Decision Support System for Asthma Management

Trial Overview The study tests an electronic Asthma Management System (eAMS-Pharm) in pharmacies. It aims to see if this computerized support helps pharmacists better manage asthma through patient data analysis and guideline-based recommendations.

How Is the Trial Designed?

Group I: Control - None Active Control 1 Intervention

A retrospective, pharmacy chart review will assess pharmacy-delivered care in the six-month pre-intervention period.

Group II: Intervention - The Electronic Asthma Management System in Pharmacies (eAMS-Pharm) Active Control 1 Intervention

Throughout the intervention period, the eAMS-Pharm will be provided to pharmacists/RPhTs/assistants/students (for use in eligible patients).

Who Is Running the Clinical Trial?

Unity Health Toronto

Lead Sponsor

Trials

572

Recruited

470,000+

Citations

1. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC6482383/

The Electronic Asthma Management System (eAMS) ... The Electronic Asthma Management System is a systematically developed and evidence-based computerised decision support tool that engages both patients and ...

2. patlynk.com patlynk.com/trial/NCT07038642

Electronic Asthma Management System for Pharmacies Using a questionnaire, patients will enter details about their asthma symptoms, which the system then analyzes to offer guidance on managing their condition.

3. ctv.veeva.com ctv.veeva.com/study/the-electronic-asthma-management-system-in-pharmacies

The Electronic Asthma Management System in Pharmacies The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to ...

4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC4265443/

Effectiveness of computerized clinical decision support ... Evidence supports the effectiveness of CCDSS in the care of people with asthma. However there is very little information of its use in COPD care.

5. sciencedirect.com sciencedirect.com/science/article/pii/S2352914823000102

Development and evaluation of a mobile-based asthma ... The ginasthma mobile-based CDSS can provide healthcare providers with an automated individualized action plan by combining patient data with embedded knowledge.

6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC4373260/

Computer decision support systems for asthma Once data related to the visit was entered, the system evaluated whether the patient had asthma or COPD, reviewed the physician's treatment of asthma and COPD, ...

7. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC7871297/

Essential Role of Pharmacists in Asthma Care and ... Results of a comprehensive review including 25 studies showed that pharmacist-led interventions improved asthma outcomes (such as asthma severity and health- ...